SeemanT., DusekJ., VondrakK.. Renal concentrating capacity is linked to blood pressure in children with autosomal dominant polycystic kidney disease.Physiol Res2004; 53: 629.
7.
GabowP.A., KaehnyW.D., JohnsonA.M.. The clinical utility of renal concentrating capacity in polycystic kidney disease.Kidney Int1989; 35: 675.
8.
EcderT., SchrierR.W.Hypertension in autosomal-dominant polycystic kidney disease: Early occurrence and unique aspects.J Am Soc Nephrol2001; 12: 194.
9.
ChapmanA.B., JohnsonA., GabowP.A., SchrierR.W.The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.N Engl J Med1990; 323: 1091.
10.
ZeierM., GeberthS., SchmidtK.G.. Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease.J Am Soc Nephrol1993; 3: 1451.
11.
BarrettB.J., FoleyR., MorganJ.. Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members.Kidney Int1994; 46: 1118.
12.
EcderT., ChapmanA.B., BrosnahanG.M.. Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease.Am J Kidney Dis2000; 35: 427.
13.
KlahrS., BryerJ.A., BeckG.J.. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease.J Am Soc Nephrol1995; 5: 2037.
14.
SchrierR., McFannK., JohnsonA.. Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: Results of a seven-year prospective randomized study.J Am Soc Nephrol2002; 13: 1733.
15.
JafarT.H., StarkP.C., SchmidC.H.. The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease.Kidney Int2005; 67: 265.
16.
SarnakM.J., GreeneT., WangX., BeckG., KusekJ.W., CollinsA.J., Levey AS (2005) The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study.Ann Intern Med142: 342–51.
17.
ElzingaL.W., BarryJ.M., TorresV.E.. Cyst decompression surgery for autosomal dominant polycystic kidney disease.J Am Soc Nephrol1992; 2: 1219.
GibsonP., WatsonM.L.Cyst infection in polycystic kidney disease: A clinical challenge.Nephrol Dial Transplant1998; 13: 2455.
29.
KeithD.S., TorresV.E., KingB.F.. Renal cell carcinoma in autosomal dominant polycystic kidney disease.J Am Soc Nephrol1994; 4: 1661.
30.
GabowP.A., JohnsonA.M., KaehnyW.D.. Factors affecting the prognosis of renal disease in autosomal-dominant polycystic kidney disease.Kidney Int1992; 41: 1311.
31.
JohnsonA.M., GabowP.A.Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease.J Am Soc Nephrol1997; 8: 1560.
32.
Fick-BrosnahanG.M., TranZ.V., JohnsonA.M.. Progression of autosomal-dominant polycystic kidney disease in children.Kidney Int2001; 59: 1654.
HateboerN., DijkM.A., BogdanovaN.. Comparison of phenotypes of polycystic kidney disease types 1 and 2.Lancet1999; 353: 103.
35.
HarrisP.C., BaeK.T., RossettiS.. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.J Am Soc Nephrol2006, 11: 3013.
36.
DalgaardO.Z.Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families.Acta Med Scand Suppl1957; 328: 1.
37.
KingB.F., ReedJ.E., BergstralhE.J.. Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease.J Am Soc Nephrol2000; 11: 1505.
38.
ChapmanA.B., Guay-WoodfordL.M., GranthamJ.J.. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The consortium for radiologic imaging studies of polycystic kidney disease (CRISP) cohort.Kidney Int2003; 64: 1035.
39.
O'NeillW.C., RobbinM.L., BaeK.T.. Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP).Am J Kidney Dis2005; 46: 1058.
40.
GranthamJ., TorresV., ChapmanA.. Volume progression in poycystic kidney disease.New Engl Med J2006; 354: 2122.
HateboerN., VeldhuisenB., PetersD.. Location of mutations within the PKD2 gene influences clinical outcome.Kidney Int2000; 57: 1444.
43.
MagistroniR., HeN., WangK., AndrewR.Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.J Am Soc Nephrol2003; 14: 1164.
44.
FickG.M., JohnsonA.M., GabowP.A.Is there evidence for anticipation in autosomal-dominant polycystic kidney disease?Kidney Int1994; 45: 1153.
45.
PersuA., DuymeM., PirsonY.. Comparison between siblings and twins supports a role for modifier genes in ADPKD.Kidney Int2004; 66: 2132.
46.
FainP.R., McFannK.K., TaylorM.R.. Modifier genes play a significant role in the phenotypic expression of PKD1.Kidney Int2005; 67: 1256.
47.
PeiY.Nature and nurture on phenotypic variability of autosomal dominant polycystic kidney disease.Kidney Int2005; 67: 1630.
48.
Guay-WoodfordL.M.Phenotypic variability in PKD1: The family as a starting point (editorial).Kidney Int1999; 56: 344.
49.
ZeierM., FehrenbachP., GeberthS.. Renal histology in polycystic kidney disease with incipient and advanced renal failure.Kidney Int1992; 42: 1259.
50.
WooD.Apoptosis and loss of renal tissue in polycystic kidney diseases.N Engl J Med1995; 333: 18.
